204 related articles for article (PubMed ID: 14659109)
1. Pharmacological prevention of breast cancer: quo vadis?
Serrano D; Bonanni B; Cazzaniga M; Galli A; Gonzaga AG; Decensi A
Breast; 2003 Dec; 12(6):379-86. PubMed ID: 14659109
[TBL] [Abstract][Full Text] [Related]
2. Progress in chemoprevention of breast cancer.
Serrano D; Perego E; Costa A; Decensi A
Crit Rev Oncol Hematol; 2004 Feb; 49(2):109-17. PubMed ID: 15012972
[TBL] [Abstract][Full Text] [Related]
3. SERMs in chemoprevention of breast cancer.
Gasco M; Argusti A; Bonanni B; Decensi A
Eur J Cancer; 2005 Sep; 41(13):1980-9. PubMed ID: 15964182
[TBL] [Abstract][Full Text] [Related]
4. Preventive therapy for breast cancer: a consensus statement.
Cuzick J; DeCensi A; Arun B; Brown PH; Castiglione M; Dunn B; Forbes JF; Glaus A; Howell A; von Minckwitz G; Vogel V; Zwierzina H
Lancet Oncol; 2011 May; 12(5):496-503. PubMed ID: 21441069
[TBL] [Abstract][Full Text] [Related]
5. Chemoprevention of breast cancer in postmenopausal women.
Geller BA; Vogel VG
Breast Dis; 2005-2006; 24():79-92. PubMed ID: 16917141
[TBL] [Abstract][Full Text] [Related]
6. Chemoprevention of breast cancer.
Cuzick J
Breast Cancer; 2008; 15(1):10-6. PubMed ID: 18224388
[TBL] [Abstract][Full Text] [Related]
7. Selective estrogen receptor modulators and aromatase inhibitors for breast cancer chemoprevention.
Vogel VG
Curr Drug Targets; 2011 Dec; 12(13):1874-87. PubMed ID: 21158712
[TBL] [Abstract][Full Text] [Related]
8. [Breakthrough in breast cancer chemoprevention].
Kahán Z; Thurzó L
Orv Hetil; 2003 Mar; 144(13):597-603. PubMed ID: 12728784
[TBL] [Abstract][Full Text] [Related]
9. Chemoprevention of breast cancer.
Zelnak AB; O'Regan RM
Curr Probl Cancer; 2004; 28(4):201-17. PubMed ID: 15318323
[No Abstract] [Full Text] [Related]
10. Chemoprevention of breast cancer in the older patient.
Minton SE
Hematol Oncol Clin North Am; 2000 Feb; 14(1):113-30. PubMed ID: 10680075
[TBL] [Abstract][Full Text] [Related]
11. American Society of Clinical Oncology technology assessment of pharmacologic interventions for breast cancer risk reduction including tamoxifen, raloxifene, and aromatase inhibition.
Chlebowski RT; Col N; Winer EP; Collyar DE; Cummings SR; Vogel VG; Burstein HJ; Eisen A; Lipkus I; Pfister DG;
J Clin Oncol; 2002 Aug; 20(15):3328-43. PubMed ID: 12149307
[TBL] [Abstract][Full Text] [Related]
12. Chemoprevention for high-risk women: tamoxifen and beyond.
Fabian CJ; Kimler BF
Breast J; 2001; 7(5):311-20. PubMed ID: 11906441
[TBL] [Abstract][Full Text] [Related]
13. American Society of Clinical Oncology technology assessment on breast cancer risk reduction strategies: tamoxifen and raloxifene.
Chlebowski RT; Collyar DE; Somerfield MR; Pfister DG
J Clin Oncol; 1999 Jun; 17(6):1939-55. PubMed ID: 10561236
[TBL] [Abstract][Full Text] [Related]
14. Selective estrogen receptor modulators (SERMs) and retinoids in breast cancer chemoprevention.
Zujewski J
Environ Mol Mutagen; 2002; 39(2-3):264-70. PubMed ID: 11921197
[TBL] [Abstract][Full Text] [Related]
15. Chemoprevention of breast cancer: a summary of the evidence for the U.S. Preventive Services Task Force.
Kinsinger LS; Harris R; Woolf SH; Sox HC; Lohr KN
Ann Intern Med; 2002 Jul; 137(1):59-69. PubMed ID: 12093250
[TBL] [Abstract][Full Text] [Related]
16. American society of clinical oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction.
Visvanathan K; Chlebowski RT; Hurley P; Col NF; Ropka M; Collyar D; Morrow M; Runowicz C; Pritchard KI; Hagerty K; Arun B; Garber J; Vogel VG; Wade JL; Brown P; Cuzick J; Kramer BS; Lippman SM;
J Clin Oncol; 2009 Jul; 27(19):3235-58. PubMed ID: 19470930
[TBL] [Abstract][Full Text] [Related]
17. Beyond tamoxifen new endpoints for breast cancer chemoprevention, new drugs for breast cancer prevention.
Fabian CJ; Kimler BF
Ann N Y Acad Sci; 2001 Dec; 952():44-59. PubMed ID: 11795443
[TBL] [Abstract][Full Text] [Related]
18. The role of selective estrogen receptor modulators in the prevention of breast cancer: comparison of the clinical trials.
Martino S; Costantino J; McNabb M; Mershon J; Bryant K; Powles T; Secrest RJ
Oncologist; 2004; 9(2):116-25. PubMed ID: 15047916
[TBL] [Abstract][Full Text] [Related]
19. Chemoprevention of breast cancer.
Osborne MP
Surg Clin North Am; 1999 Oct; 79(5):1207-21. PubMed ID: 10572559
[TBL] [Abstract][Full Text] [Related]
20. Breast Cancer Chemoprevention among High-risk Women and those with Ductal Carcinoma In Situ.
Reimers LL; Sivasubramanian PS; Hershman D; Terry MB; Greenlee H; Campbell J; Kalinsky K; Maurer M; Jayasena R; Sandoval R; Alvarez M; Crew KD
Breast J; 2015; 21(4):377-86. PubMed ID: 25879521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
